EMCURE / NSE / Biotechnology & Drugs
Emcure Pharmaceuticals
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High1,944
Target Low1,260.1
Target Mean1.33
Target Median41.67
Risk Metrics
Overall RiskBalanced risk
Board Risk34.26
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Emcure Pharmaceuticals Ltd. Share Price Today - Emcure Pharmaceuticals Ltd. Stock Price Live NSE/BSE CNBC TV18
Emcure Partner Novo Nordisk's Wegovy Gets CDSCO Approval For Fatty Liver Disease Sahi
Emcure Pharma Schedules Q1 FY27 Board Meeting on August 6; Concall at 4 PM IST Sahi
Emcure Pharmaceuticals to discuss Q1 FY27 results on August 6 scanx.trade
Pharma stock in focus after agreement to acquire remaining 12% stake in its subsidiary MSN
Emcure Pharmaceuticals Acquires Full Ownership of Gennova, Appoints Samit Mehta as CEO Digital Health News
Stock FAQs
What is the symbol and ISIN of Emcure Pharmaceuticals?
Emcure Pharmaceuticals has the symbol EMCURE and ISIN - INE168P01015.
What is the current price of Emcure Pharmaceuticals?
Emcure Pharmaceuticals is currently trading at INR 1,783.90.
What are the year high and year low of Emcure Pharmaceuticals?
Emcure Pharmaceuticals has a year high of INR 1,944.00 and a year low of INR 1,260.10.
What is the market capitalization of Emcure Pharmaceuticals?
Emcure Pharmaceuticals has a market capitalization of INR 33,716.15 crore.
What is the P/E ratio of Emcure Pharmaceuticals?
Emcure Pharmaceuticals has a P/E ratio of 32.71.
What is the dividend yield of Emcure Pharmaceuticals?
Emcure Pharmaceuticals has a dividend yield of 0.20%.
How is the financial performance of Emcure Pharmaceuticals based on revenue, net income, and EPS?
Emcure Pharmaceuticals has revenue of INR 92,035.40 crore, net income of INR 9,243.61 crore, and EPS of INR 50.00.
What is the book value of Emcure Pharmaceuticals?
Emcure Pharmaceuticals has a book value of INR 203.01.
What is the debt-to-equity ratio of Emcure Pharmaceuticals?
Emcure Pharmaceuticals has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Emcure Pharmaceuticals?
Emcure Pharmaceuticals has a price-to-book ratio of 8.79 and a price-to-sales ratio of 0.37.
© SharekeyX | Rusaka Technologies 2024-2026